RenovoRx RNXT
NASDAQ RNXT
$1.56 -0.01 (-0.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Research & Development (2020 - 2026)

Updated

RenovoRx's Research & Development came in at $1.2 million for Q2 2026, down 15.8% from $1.43 million a year earlier and down 2.3% from the prior quarter.

Analysis

RenovoRx (RNXT) Research & Development (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, RenovoRx reported Research & Development of $5.61 million, down 10.8% year-over-year; for FY2025, it came in at $6.27 million, up 4.0% from FY2024.

  • Research & Development has increased in each of the last five years, with a five-year compound annual growth rate of 21.3% (FY2020 to FY2025).
  • Going back by year, Research & Development was $6.03 million in FY2024 (+6.3%), $5.67 million in FY2023 (+31.8%), $4.3 million in FY2022 (+41.5%) and $3.04 million in FY2021 (+27.4%).
  • The Q2 2026 figure represents the lowest quarterly Research & Development since Q4 2023.
  • Year-over-year, Research & Development has declined for three consecutive quarters, with growth averaging 10.5% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in Q2 2022 (growth of 159.3%), and the weakest in Q4 2022 (a decline of 29.5%).
  • Business Quant data shows RNXT's Research & Development at $1.23 million (Q1 2026), $1.5 million (Q4 2025) and $1.69 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 364.00 Mn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 892.00 Mn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 412.00 Mn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 370.60 Mn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 771.00 Mn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 434.00 Mn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 554.00 Mn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 278.90 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 258.00 Mn
10 RenovoRx 70.84 Mn 70.84 Mn 766,000.00 1.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Mn
Mar 31, 2026 1.23 Mn
Dec 31, 2025 1.50 Mn
Sep 30, 2025 1.69 Mn
Jun 30, 2025 1.43 Mn
Mar 31, 2025 1.64 Mn
Dec 31, 2024 1.58 Mn
Sep 30, 2024 1.65 Mn
Jun 30, 2024 1.54 Mn
Mar 31, 2024 1.26 Mn
Dec 31, 2023 775,000.00
Sep 30, 2023 1.63 Mn
Jun 30, 2023 1.93 Mn
Mar 31, 2023 1.34 Mn
Dec 31, 2022 776,000.00
Sep 30, 2022 846,000.00
Jun 30, 2022 1.39 Mn
Mar 31, 2022 1.29 Mn
Dec 31, 2021 1.10 Mn
Sep 30, 2021 767,000.00
API Access

RenovoRx Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=RNXT&period=max&api_key=YOUR_API_KEY